Investing Profile

Michael Anstey

InvestorVC
Partner at Cambridge Innovation Capital
cic.vc/team/Cambridge, United Kingdom
Photo of Michael Anstey, Partner at Cambridge Innovation Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$600K - $6.0M
$3.3M
3
£225M
CompanyStageDateRound SizeTotal Raised
Immutrin
Series AMar 2026$87M
$87M
Co-investors: Nihal Sinha (F-Prime Capital Partners), James N. Topper (Frazier Healthcare Partners)
TRIMTECH Therapeutics
SeedMar 2025$31M
$31M
Co-investors: Hakan Goker (M Ventures (Merck)), Laurence Barker (SV Health Investors), Jeffrey Moore (MP Healthcare Venture Management)
PredictImmune
Series BJul 2019$12M
$25M
Co-investors: Alastair Kilgour (Parkwalk Advisors)